HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Roundup: Wellnext, APha On Dosing, Canada-EU Organic Pact

This article was originally published in The Tan Sheet

Executive Summary

Wellnext buys supplement firm; APhA urges mL liquid dosing standard; RLA Collective continues health, wellness focus; and more news in brief.

You may also be interested in...



Clorox Acts On Tax Reform Excitement With Nutritional Sector Acquisition

Clorox is acquiring Nutranext, manufacturer and marketer of dietary supplement brands including Rainbow Light and Natural Vitality, a month after executives said during the firm's latest earnings briefing that US tax code change, particularly eliminating taxing income earned in foreign markets when it is transferred to the US, heightens their interest in mergers and acquisitions. Expect more from Clorox and in the broader health care space, says analysts.

Liquid Dosing Accuracy Four-Times Better With Oral Syringes – Study

Pediatric OTC and Rx dosage errors reach 43% for parents using a dosing cup but 16.7% with a 0.2 mL oral syringe, according to researchers who say recommending oral syringes over cups, particularly for small doses, should be part of a comprehensive pediatric labeling and dosing strategy.

Liquid Dosing Accuracy Four-Times Better With Oral Syringes – Study

Pediatric OTC and Rx dosage errors reach 43% for parents using a dosing cup but 16.7% with a 0.2 mL oral syringe, according to researchers who say recommending oral syringes over cups, particularly for small doses, should be part of a comprehensive pediatric labeling and dosing strategy.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108840

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel